08/14/2025
5:04 PM | Cogent Biosciences (Subject)
Cogent Biosciences, Inc. (Subject)
Venrock Healthcare Capital Partners II, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
08/14/2025
4:05 PM | Cogent Biosciences (Subject)
Cogent Biosciences, Inc. (Subject)
Commodore Capital LP (Filed by)
| Form SCHEDULE 13G/A | |
08/14/2025
4:07 PM | Cogent Biosciences (Subject)
Cogent Biosciences, Inc. (Subject)
Commodore Capital LP (Filed by)
| Form SCHEDULE 13G | |
08/05/2025
7:41 AM | Cogent Biosciences (Filer)
Cogent Biosciences, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/05/2025
7:46 AM | Cogent Biosciences (Filer)
Cogent Biosciences, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/14/2025
3:30 PM | Cogent Biosciences (Issuer)
Cogent Biosciences, Inc. (Issuer)
Fairmount Funds Management LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/14/2025
3:31 PM | Cogent Biosciences (Subject)
Cogent Biosciences, Inc. (Subject)
Fairmount Funds Management LLC (Filed by)
| Form SCHEDULE 13D/A | |
07/11/2025
7:19 AM | Cogent Biosciences (Subject)
Cogent Biosciences, Inc. (Subject)
Flynn James E (Filed by)
| Form SCHEDULE 13G | |
07/10/2025
7:00 AM | Cogent Biosciences (Filer)
Cogent Biosciences, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/09/2025
3:46 PM | Cogent Biosciences (Filer)
Cogent Biosciences, Inc. (Filer)
| Form 424B5 | |
07/08/2025
4:14 PM | Cogent Biosciences (Filer)
Cogent Biosciences, Inc. (Filer)
| Form 424B5 | |
Get the Latest News and Ratings for COGT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Cogent Biosciences and its competitors with MarketBeat's FREE daily newsletter. |
07/07/2025
6:15 AM | Cogent Biosciences (Filer)
Cogent Biosciences, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/11/2025
7:15 AM | Cogent Biosciences (Filer)
Cogent Biosciences, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2025
3:17 PM | Cogent Biosciences (Issuer)
Cogent Biosciences, Inc. (Issuer)
Morris Arlene (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2025
3:19 PM | Cogent Biosciences (Issuer)
Cogent Biosciences, Inc. (Issuer)
Harwin Peter Evan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2025
3:21 PM | Cogent Biosciences (Issuer)
Cogent Biosciences, Inc. (Issuer)
Shegog Todd (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2025
3:21 PM | Cogent Biosciences (Issuer)
Cogent Biosciences, Inc. (Issuer)
Ros Matthew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2025
3:24 PM | CAIN CHRISTOPHER W. (Reporting)
Cogent Biosciences (Issuer)
Cogent Biosciences, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2025
3:25 PM | Cogent Biosciences (Issuer)
Cogent Biosciences, Inc. (Issuer)
Ferrante Karen Jean (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2025
7:15 AM | Cogent Biosciences (Filer)
Cogent Biosciences, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2025
3:39 PM | Cogent Biosciences (Subject)
Cogent Biosciences, Inc. (Subject)
Paradigm Biocapital Advisors LP (Filed by)
| Form SCHEDULE 13G/A | |
05/11/2025
11:15 PM | Cogent Biosciences (Filer)
Cogent Biosciences, Inc. (Filer)
| Form EFFECT | |
05/06/2025
8:00 AM | Cogent Biosciences (Filer)
Cogent Biosciences, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/06/2025
7:19 AM | Cogent Biosciences (Filer)
Cogent Biosciences, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2025
7:05 AM | Cogent Biosciences (Filer)
Cogent Biosciences, Inc. (Filer)
| Form POS AM | |
05/06/2025
7:10 AM | Cogent Biosciences (Filer)
Cogent Biosciences, Inc. (Filer)
| Form 424B5 | |
04/22/2025
3:40 PM | Cogent Biosciences (Filer)
Cogent Biosciences, Inc. (Filer)
| Form ARS | |
04/22/2025
3:31 PM | Cogent Biosciences (Filer)
Cogent Biosciences, Inc. (Filer)
| Form DEF 14A | |
04/22/2025
3:35 PM | Cogent Biosciences (Filer)
Cogent Biosciences, Inc. (Filer)
| Form DEFA14A | |
04/11/2025
5:28 PM | Cogent Biosciences (Subject)
Cogent Biosciences, Inc. (Subject)
Venrock Healthcare Capital Partners II, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
02/25/2025
7:38 AM | Cogent Biosciences (Filer)
Cogent Biosciences, Inc. (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/25/2025
7:20 AM | Cogent Biosciences (Filer)
Cogent Biosciences, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2025
8:28 AM | Cogent Biosciences (Subject)
Cogent Biosciences, Inc. (Subject)
FMR LLC (Filed by)
| Form SCHEDULE 13G/A | |
01/27/2025
4:03 PM | Cogent Biosciences (Issuer)
Cogent Biosciences, Inc. (Issuer)
Green John L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
3:55 PM | Cogent Biosciences (Issuer)
Cogent Biosciences, Inc. (Issuer)
Kearns Evan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
3:56 PM | Cogent Biosciences (Issuer)
Cogent Biosciences, Inc. (Issuer)
Robbins Andrew R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
3:56 PM | Cogent Biosciences (Issuer)
Cogent Biosciences, Inc. (Issuer)
Sachs Jessica (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
3:58 PM | Cogent Biosciences (Issuer)
Cogent Biosciences, Inc. (Issuer)
Robinson John Edward (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
4:00 PM | Cogent Biosciences (Issuer)
Cogent Biosciences, Inc. (Issuer)
Pinnow Cole (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2025
6:00 AM | Cogent Biosciences (Issuer)
Cogent Biosciences, Inc. (Issuer)
Pinnow Cole (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
3:21 PM | Cogent Biosciences (Issuer)
Cogent Biosciences, Inc. (Issuer)
Ferrante Karen Jean (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
The Coin That Could Define Trump’s Crypto Presidency (Ad) When Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top advisor on crypto and AI. That alone signaled a shift. But insiders close to D.C. aren’t just talking crypto policy—they’re quietly buying something most retail investors have missed.
While the crowd chases Bitcoin to $150,000, Weiss Ratings expert Juan Villaverde believes a different coin—already backed by giants like Google, Visa, and PayPal—could soon become crypto’s “Third Giant.” Discover the coin that could define Trump’s crypto presidency. |
11/14/2024
6:59 PM | Cogent Biosciences (Subject)
Cogent Biosciences, Inc. (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024
4:47 PM | Cogent Biosciences (Subject)
Cogent Biosciences, Inc. (Subject)
Venrock Healthcare Capital Partners II, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024
11:24 AM | Cogent Biosciences (Subject)
Cogent Biosciences, Inc. (Subject)
Kynam Capital Management, LP (Filed by)
| Form SC 13G/A | |
11/07/2024
8:24 AM | Cogent Biosciences (Subject)
Cogent Biosciences, Inc. (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
11/07/2024
8:12 AM | Cogent Biosciences (Subject)
Cogent Biosciences, Inc. (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
09/03/2024
7:15 AM | Cogent Biosciences (Filer)
Cogent Biosciences, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
MarketBeat All Access